Immune Disorders Drugs Market Research Reports

Global Rheumatic Disorders Drugs Market to 2024 - Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry - Product Thumbnail Image

Global Rheumatic Disorders Drugs Market to 2024 - Increased Uptake of IL Inhibitors and JAK Inhibitors to Drive Growth as TNF Inhibitors Face Patent Expiry

  • Report
  • 180 Pages
From
Atopic Dermatitis Therapeutics in Southeast Asia Markets to 2024 - Growth Driven by Rising Awareness and Expected Launch of Novel Therapies - Product Thumbnail Image

Atopic Dermatitis Therapeutics in Southeast Asia Markets to 2024 - Growth Driven by Rising Awareness and Expected Launch of Novel Therapies

  • Report
  • 113 Pages
From
Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market - Product Thumbnail Image

Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market

  • Report
  • 125 Pages
From
Immunotherapeutic Drugs, Devices & Patient Enablement - Product Thumbnail Image

Immunotherapeutic Drugs, Devices & Patient Enablement

  • Report
From
Biological Autoimmune Therapeutics - Product Thumbnail Image

Biological Autoimmune Therapeutics

  • Report
From
Cancer Immunotherapy Market By Type (Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy), Application (Lung, Breast, Multiple Myeloma, Colorectal, Melanoma, Prostate), And End User– Global Forecast To 2024 - Product Thumbnail Image

Cancer Immunotherapy Market By Type (Monoclonal Antibodies, Checkpoint Inhibitors, Immunomodulators, Vaccines, Cell Therapy), Application (Lung, Breast, Multiple Myeloma, Colorectal, Melanoma, Prostate), And End User– Global Forecast To 2024

  • Report
  • 173 Pages
From
Mucopolysaccharidosis Disorders Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Mucopolysaccharidosis Disorders Drug Development Pipeline Review, 2018

  • Report
  • 98 Pages
From
Epiomic Epidemiology Series: Primary Immunodeficiency Diseases Forecast In 23 Major Markets 2018-2028 - Product Thumbnail Image

Epiomic Epidemiology Series: Primary Immunodeficiency Diseases Forecast In 23 Major Markets 2018-2028

  • Report
  • 66 Pages
From
Epiomic Epidemiology Series: Mucopolysaccharidosis Type I Forecast In 27 Major Markets 2018–2028 - Product Thumbnail Image

Epiomic Epidemiology Series: Mucopolysaccharidosis Type I Forecast In 27 Major Markets 2018–2028

  • Report
  • 74 Pages
From
Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay, Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023 - Product Thumbnail Image

Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay, Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023

  • Report
  • 158 Pages
From
Rhinitis: Market Intelligence Review and Insights - Product Thumbnail Image

Rhinitis: Market Intelligence Review and Insights

  • Report
  • 50 Pages
From
Mammalian Polyclonal IgG Antibody Market Size, Share & Trends Analysis Report By Type (Mouse, Rabbit), By Product (Cardiac, Metabolic), By Application, By End Use, By Region, And Segment Forecasts, 2018 - 2025 - Product Thumbnail Image

Mammalian Polyclonal IgG Antibody Market Size, Share & Trends Analysis Report By Type (Mouse, Rabbit), By Product (Cardiac, Metabolic), By Application, By End Use, By Region, And Segment Forecasts, 2018 - 2025

  • Report
  • 109 Pages
From
U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market Size, Share & Trends Analysis Report By Treatment, By End User (Dermatology Clinics, Hospitals), And Segment Forecasts, 2018 - 2025 - Product Thumbnail Image

U.S. PRP (Platelet Rich Plasma) and Stem Cell Alopecia Treatment Market Size, Share & Trends Analysis Report By Treatment, By End User (Dermatology Clinics, Hospitals), And Segment Forecasts, 2018 - 2025

  • Report
  • 45 Pages
From
Global Allergic Conjunctivitis Market, Patients, Treated Patients, by Countries (India, China, Japan, US, UK, etc), Disease Type (SAC, PAC, VKC, AKC, GPC), Drugs Profile (Zerviate, OTX-DP, ADX-102, PRT-2761) Companies, Growth Drivers & Challenges - Product Thumbnail Image

Global Allergic Conjunctivitis Market, Patients, Treated Patients, by Countries (India, China, Japan, US, UK, etc), Disease Type (SAC, PAC, VKC, AKC, GPC), Drugs Profile (Zerviate, OTX-DP, ADX-102, PRT-2761) Companies, Growth Drivers & Challenges

  • Report
  • 127 Pages
From
Rhinitis: Epidemiology Overview and Insights - Product Thumbnail Image

Rhinitis: Epidemiology Overview and Insights

  • Report
  • 50 Pages
From
Psoriasis Drugs Market Analysis Report by Therapeutic Class (Interleukin-inhibitors, Tumor Necrosis Factor-inhibitors), by Treatment (Topicals, Systemic, Biologics), and Segment Forecasts, 2016 - 2022 - Product Thumbnail Image

Psoriasis Drugs Market Analysis Report by Therapeutic Class (Interleukin-inhibitors, Tumor Necrosis Factor-inhibitors), by Treatment (Topicals, Systemic, Biologics), and Segment Forecasts, 2016 - 2022

  • Report
  • 115 Pages
From
Global PD-1 and PD-L1 Inhibitors Market 2019-2023 - Product Thumbnail Image

Global PD-1 and PD-L1 Inhibitors Market 2019-2023

  • Report
  • 116 Pages
From
Global Epidermolysis Bullosa Therapeutics Market 2019-2023 - Product Thumbnail Image

Global Epidermolysis Bullosa Therapeutics Market 2019-2023

  • Report
  • 128 Pages
From
Systemic Lupus Erythematosus Market Size, Share & Trends Analysis Report by Drug Class (Immunosuppressants, Biologics, Antimalarials, NSAIDs, Corticosteroids), By Route of Administration, and Segment Forecasts 2018 - 2025 - Product Thumbnail Image

Systemic Lupus Erythematosus Market Size, Share & Trends Analysis Report by Drug Class (Immunosuppressants, Biologics, Antimalarials, NSAIDs, Corticosteroids), By Route of Administration, and Segment Forecasts 2018 - 2025

  • Report
  • 77 Pages
From
Intravenous Immunoglobulin (IVIg) - Global Strategic Business Report - Product Thumbnail Image

Intravenous Immunoglobulin (IVIg) - Global Strategic Business Report

  • Report
  • 187 Pages
From
Loading Indicator
adroll